Immune System News and Research

RSS

Combination of two antibodies prevents growth and spread of triple-negative breast tumors

Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells - receptors for the hormones estrogen or progesterone, or a co-receptor, called HER2, that binds to many growth factors. But about one in every six breast tumors has none of these receptors. Such cancers, called triple-negative, are particularly aggressive and notoriously difficult to treat.

10 Feb 2013

Virginia Tech researchers reveal how 'bad' gut bacteria may help control diabetes

A stomach bacterium believed to cause health problems such as gastritis, ulcers, and gastric cancer may play a dual role by balancing the stomach's ecosystem and controlling body weight and glucose tolerance, according to immunologists at the Virginia Bioinformatics Institute of Virginia Tech.

10 Feb 2013

Research sheds light on how E. coli thrive in the intestine of people with IBD

Scientists have long puzzled over why "bad" bacteria such as E. coli can thrive in the guts of those with inflammatory bowel disease (IBD), causing serious diarrhea. Now UC Davis researchers have discovered the answer-one that may be the first step toward finding new and better treatments for IBD.

10 Feb 2013

Reprogrammed human skin cells highly effective in treating myelin disorders

A study out today in the journal Cell Stem Cell shows that human brain cells created by reprogramming skin cells are highly effective in treating myelin disorders, a family of diseases that includes multiple sclerosis and rare childhood disorders called pediatric leukodystrophies.

10 Feb 2013

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.

10 Feb 2013

TIC10 may improve usefulness of TRAIL protein in cancer therapy

A compound that stimulates the production of a tumor-fighting protein may improve the usefulness of the protein in cancer therapy, according to a team of researchers.

9 Feb 2013

Milk thistle constituent shows promising skin protection properties

Silibinin, a key component of milk thistle seeds, can help protect against skin damage caused by ultraviolet B radiation, show study findings published in Molecular Carcinogenesis.

8 Feb 2013

Researchers identify an exceptional mouse model of schizophrenia

Researchers at the Institute for Comprehensive Medical Science, Fujita Health University and the National Institute for Physiological Sciences, Japan, along with colleagues from 9 other institutions, have identified an exceptional mouse model of schizophrenia.

7 Feb 2013

Drug-carrying nanoparticles have another hurdle to overcome - escaping the bloodstream

Many medically minded researchers are in hot pursuit of designs that will allow drug-carrying nanoparticles to navigate tissues and the interiors of cells, but University of Michigan engineers have discovered that these particles have another hurdle to overcome: escaping the bloodstream.

7 Feb 2013

First new TB vaccine in century fails initial testing

The first of a series of new vaccines that have been developed to combat tuberculosis failed to show efficacy compared with placebo in South African infants, show results from a phase II trial.

7 Feb 2013

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

Deadly flu viruses, including the H5N1 bird flu and H3N2 swine flu, may have met their match in FluGen's universal vaccine, REDEE FLU.

6 Feb 2013

Experimental TB vaccine does not protect infants, study shows

"Hopes that a much needed new tuberculosis [TB] vaccine was on the way, the first for 90 years, have been dashed by trial results showing it did not protect babies against the disease," the Guardian reports.

6 Feb 2013

Boston College biologist to explore connection between peripheral neuropathy and HIV

Boston College biologist Tricia Burdo has been awarded a five-year, $1.9 million grant from the National Institutes of Health to study the role of the body's immune response in a debilitating form of nerve damage suffered by people living with HIV.

6 Feb 2013

GSTM gene mutation, air pollution can increase risk of asthma-related cockroach allergy

An allergic reaction to cockroaches is a major contributor to asthma in urban children, but new research suggests that the insects are just one part of a more complex story. Very early exposure to certain components of air pollution can increase the risk of developing a cockroach allergy by age 7 and children with a common mutation in a gene called GSTM may be especially vulnerable.

6 Feb 2013

Three NIH-sponsored influenza trials begin to enroll volunteers

Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at several dozen other domestic and international sites.

6 Feb 2013

Researchers pinpoint how vitamin D3 and omega-3 may boost immunity to help fight Alzheimer's

A team of academic researchers has pinpointed how vitamin D3 and omega-3 fatty acids may enhance the immune system's ability to clear the brain of amyloid plaques, one of the hallmarks of Alzheimer's disease.

5 Feb 2013

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex, Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine.

5 Feb 2013

Immune System News and Research

Combination of two antibodies prevents growth and spread of triple-negative breast tumors

Virginia Tech researchers reveal how 'bad' gut bacteria may help control diabetes

Research sheds light on how E. coli thrive in the intestine of people with IBD

Reprogrammed human skin cells highly effective in treating myelin disorders

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

TIC10 may improve usefulness of TRAIL protein in cancer therapy

Milk thistle constituent shows promising skin protection properties

Researchers identify an exceptional mouse model of schizophrenia

Drug-carrying nanoparticles have another hurdle to overcome - escaping the bloodstream

First new TB vaccine in century fails initial testing

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

Experimental TB vaccine does not protect infants, study shows

Boston College biologist to explore connection between peripheral neuropathy and HIV

GSTM gene mutation, air pollution can increase risk of asthma-related cockroach allergy

Three NIH-sponsored influenza trials begin to enroll volunteers

Researchers pinpoint how vitamin D3 and omega-3 may boost immunity to help fight Alzheimer's

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Injection-free vaccination technique shows promise

Results from Merck’s Vorinostat phase 1 trial on lymphoma

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

Immunology eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News